University of Michigan Cancer Center
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT02444195
The purpose of this study is to evaluate the effectiveness of self-administered perioperative guided imagery to reduce perioperative distress in gynecologic oncology patients undergoing surgical management for a presumed cancer diagnosis.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects assigned to the experimental arm will be asked to participate in meditation daily using the audio media provided for the 7 days prior to surgery, in the preoperative holding area, for the 7 days following surgery, and are encouraged to engage in affirmations module use at least weekly in the 6-8 week postoperative period.
Time frame: postoperative day 1
Time frame: 6-8 week postoperative exam
Time frame: postoperative day 1 and 6-8 week postoperative exam
Time frame: postoperative day 1 and 6-8 week postoperative exam
Time frame: postoperative day 1 and 6-8 week postoperative exam
Time frame: postoperative day 1 and 6-8 week postoperative exam
Time frame: postoperative day 1 and 6-8 week postoperative exam
Time frame: 6-8 week postoperative visit
Time frame: postoperative day 1 and 6-8 week postoperative exam
Time frame: postoperative day 1 and 6-8 week postoperative exam
University of Michigan
Other
Self-Administered Guided Imagery in the Perioperative Period to Reduce Postoperative Distress in Gynecologic Oncology Patients: A Randomized Control Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01654458
Adnexal Diseases, Endocrine Gland Neoplasms
New York, United States
View Trial DetailsNCT04351139
Adnexal Diseases, Breast Neoplasm Female
Bron, France
View Trial DetailsNCT02786524
Abdominal Neoplasms, Adnexal Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT05242861
Adnexal Diseases, Brachytherapy
Hangzhou, Zhejiang, China
View Trial Details